Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia, in Relapse

Explore clinical trials studying Acute Myeloid Leukemia, in Relapse. Study availability and eligibility vary by location and protocol.

31 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia, in Relapse trial results

Recruiting

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

NCT06459024

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Disease Attributes, +10 more
Locations
  • University Hospital Aachen Aachen, Germany
  • University Hospital Greifswald Greifswald, Germany
  • University Hospital Halle Halle, Germany
  • University Hospital of Rostock Rostock, Germany
View all 40 locations
View Trial Details
Recruiting

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

NCT06017258

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, +9 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

NCT07011004

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

NCT06372717

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, +17 more
Locations
  • Monash Health Clayton, Victoria, Australia
  • St. Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • Hollywood Private Hospital Nedlands, Western Australia, Australia
View Trial Details
Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

NCT05735184

Conditions
AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, +19 more
Locations
  • Mayo Clinic - Phoenix Phoenix, Arizona, United States
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA - Bowyer Oncology Center Los Angeles, California, United States
View all 44 locations
View Trial Details

Related conditions